GENE-THERAPY AND ENDOTHELIAL-CELL TARGETING FOR CANCER

[21] KUMAR RS, 1991, J BIOL CHEM, V266, P3854

[22] LAZO JS, 1984, J PHARMACOL EXP THER, V231, P583

[23] ENDOTHELIAL INJURY CAUSED BY ANTINEOPLASTIC AGENTS [J]. BIOCHEMICAL PHARMACOLOGY, 1986, 35 (12) : 1919 - 1923

[24] BLEOMYCIN - A PHARMACOLOGICAL TOOL IN THE STUDY OF THE PATHOGENESIS OF INTERSTITIAL PULMONARY FIBROSIS [J]. PHARMACOLOGY & THERAPEUTICS, 1990, 47 (03) : 347 - 358

[25] ADENOVIRUS-MEDIATED TRANSFER OF A RECOMBINANT HUMAN ALPHA-1-ANTITRYPSIN CDNA TO HUMAN ENDOTHELIAL-CELLS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (14) : 6482 - 6486

[26] CHARACTERIZATION OF INVIVO IMMUNOLIPOSOME TARGETING TO PULMONARY ENDOTHELIUM [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (11) : 978 - 984

[27] LIPID-COMPOSITION IS IMPORTANT FOR HIGHLY EFFICIENT TARGET BINDING AND RETENTION OF IMMUNOLIPOSOMES [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (15) : 5744 - 5748

[28] COMPLETION OF THE NUCLEOTIDE-SEQUENCE OF THE CENTRAL REGION OF TN5 CONFIRMS THE PRESENCE OF 3 RESISTANCE GENES [J]. NUCLEIC ACIDS RESEARCH, 1985, 13 (01) : 195 - 205

[29] MODZELEWSKI R A, 1992, Proceedings of the American Association for Cancer Research Annual Meeting, V33, P100

[30] PHLEOMYCIN RESISTANCE AS A DOMINANT SELECTABLE MARKER IN CHO CELLS [J]. SOMATIC CELL AND MOLECULAR GENETICS, 1988, 14 (03) : 243 - 252

[21] KUMAR RS, 1991, J BIOL CHEM, V266, P3854

[22] LAZO JS, 1984, J PHARMACOL EXP THER, V231, P583

[23] ENDOTHELIAL INJURY CAUSED BY ANTINEOPLASTIC AGENTS [J]. BIOCHEMICAL PHARMACOLOGY, 1986, 35 (12) : 1919 - 1923

[24] BLEOMYCIN - A PHARMACOLOGICAL TOOL IN THE STUDY OF THE PATHOGENESIS OF INTERSTITIAL PULMONARY FIBROSIS [J]. PHARMACOLOGY & THERAPEUTICS, 1990, 47 (03) : 347 - 358

[25] ADENOVIRUS-MEDIATED TRANSFER OF A RECOMBINANT HUMAN ALPHA-1-ANTITRYPSIN CDNA TO HUMAN ENDOTHELIAL-CELLS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (14) : 6482 - 6486

[26] CHARACTERIZATION OF INVIVO IMMUNOLIPOSOME TARGETING TO PULMONARY ENDOTHELIUM [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (11) : 978 - 984

[27] LIPID-COMPOSITION IS IMPORTANT FOR HIGHLY EFFICIENT TARGET BINDING AND RETENTION OF IMMUNOLIPOSOMES [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (15) : 5744 - 5748

[28] COMPLETION OF THE NUCLEOTIDE-SEQUENCE OF THE CENTRAL REGION OF TN5 CONFIRMS THE PRESENCE OF 3 RESISTANCE GENES [J]. NUCLEIC ACIDS RESEARCH, 1985, 13 (01) : 195 - 205

[29] MODZELEWSKI R A, 1992, Proceedings of the American Association for Cancer Research Annual Meeting, V33, P100

[30] PHLEOMYCIN RESISTANCE AS A DOMINANT SELECTABLE MARKER IN CHO CELLS [J]. SOMATIC CELL AND MOLECULAR GENETICS, 1988, 14 (03) : 243 - 252